Twinbeech Capital LP Neogenomics Inc Transaction History

Twinbeech Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.01 - $15.77 $477,571 - $578,885	36,708 New	36,708 $509,000
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $1.74 Million - $2.56 Million	143,359 Added 621.81%	166,414 $2.05 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $325,075 - $457,180	23,055 New	23,055 $370,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $469,155 - $770,584	59,689 New	59,689 $514,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $1.14 Million - $2.26 Million	-161,737 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $1.97 Million - $5.71 Million	161,737 New	161,737 $1.97 Million

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.